# Concentrix Corporation (CNXC) · Edgar & Edgarette company card

> Concentrix (CNXC) grew revenue 2.2% in FY2025 to $9.8 billion, operating margin -9.3% against a 7.9% median for business services, equity 25.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1803599 · fiscal year ended 2025-11-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/CNXC) · [JSON](https://www.pops4.com/boards/company/CNXC.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $9.8B |
| Revenue growth, 1 year | 2.2% |
| Revenue growth per year | 15.2% |
| Operating margin | -9.3% (prior year 6.2%) |
| Net margin | -13.0% |
| Operating cash flow | $807M |
| Capital spending | $234M |
| Free cash flow | $572M |
| Cash | $327M |
| Long-term debt | $4.6B |
| Total assets | $10.8B |
| Total equity | $2.7B |
| Equity ÷ assets | 25.5% |
| Return on equity | -46.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 0.27 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Beneish M: -3.4 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · operating loss: a margin of -9.3% in FY2025
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $9.8B (FY2025), total debt $4.6B. Experience: revenue up 2.2% on the year, up 15.2% a year over 4 years; operating margin -9.3%, down from 6.2%. Soundness: equity 25.5% of assets, return on equity -46.6%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $9.0B and $12.2B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $8.1B to $13.6B. A statistical range, not company guidance. Against peers (70 filers, $50M+ revenue, services-business services, nec): operating margin -9.3% against a 7.9% median; growth 2.2% against 10.2%.

Range logged 2026-09-24, receipt 00b08e92cc1e8718, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-11-03 ([filing](https://www.sec.gov/Archives/edgar/data/1803599/000180359926000160/0001803599-26-000160-index.htm))

## Recent filings

- 8-K · filed 2026-11-03 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1803599/000180359926000160/0001803599-26-000160-index.htm)
- 10-Q · filed 2026-10-07 · [filing](https://www.sec.gov/Archives/edgar/data/1803599/000180359926000155/0001803599-26-000155-index.htm)
- 8-K · filed 2026-09-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1803599/000180359926000147/0001803599-26-000147-index.htm)
- 8-K · filed 2026-09-18 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1803599/000180359926000142/0001803599-26-000142-index.htm)
- 8-K · filed 2026-07-24 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1803599/000180359926000139/0001803599-26-000139-index.htm)
- 10-Q · filed 2026-07-02 · [filing](https://www.sec.gov/Archives/edgar/data/1803599/000180359926000136/0001803599-26-000136-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001803599.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1803599

## Cite

POPS4, Edgar & Edgarette: Concentrix Corporation (CNXC) company card, from the company's own SEC filings, accessed 2026-11-06, https://www.pops4.com/boards/company/CNXC. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.